SOLITAIRE™ FR With the Intention For Thrombectomy (SWIFT) Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 144 participants.
Also called NCT01054560
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 144 participants
- Registry
-
NCT01054560
-
- Other papers using this trial's data
- Impact of Glucose on Outcomes in Patients Treated With Mechanical Thrombectomy: A Post Hoc Analysis of the Solitaire Flow Restoration With the Intention for Thrombectomy Study
- Rapid learning curve for Solitaire FR stent retriever therapy: evidence from roll-in and randomised patients in the SWIFT trial
- Serial Alberta Stroke Program early CT score from baseline to 24 hours in Solitaire Flow Restoration with the Intention for Thrombectomy study: a novel surrogate end point for revascularization in acute stroke
- Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01054560. Randomized; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2011-07 (actual). Results posted on 2016-10-26.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SOLITAIRE™ FR With the Intention For Thrombectomy (SWIFT) Study
- Acronym
- SWIFT
- Condition
- Ischemic Stroke
- Intervention (Device)
- SOLITAIRE™ Device
- Intervention (Device)
- MERCI® Device
- Lead sponsor
- Medtronic Neurovascular Clinical Affairs
Record details
- Record id
cardio:ct-nct01054560- Content hash
92c4a975f7fc9dfb70080c5b3926b3007b1ca11735631835d0ebb2f3d8a2ef30